BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND RUNX1T1, ENSG00000079102, 862
302 results:

  • 1. Testing an Intervention to Improve Health Care Worker Well-Being During the COVID-19 Pandemic: A Cluster Randomized Clinical Trial.
    Meredith LS; Ahluwalia S; Chen PG; Dong L; Farmer CM; Bouskill KE; Dalton S; Qureshi N; Blagg T; Timmins G; Schulson LB; Huilgol SS; Han B; Williamson S; Watson P; Schnurr PP; Martineau M; Davis K; Cassells A; Tobin JN; Gidengil C
    JAMA Netw Open; 2024 Apr; 7(4):e244192. PubMed ID: 38687482
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Veno-venous extracorporeal membrane oxygenation for capillary leak syndrome during induction chemotherapy in acute myeloid leukemia].
    Okamura T; Murata S; Miyamoto K; Tane M; Okabe Y; Takeda S; Tabata S; Kosako H; Hori Y; Yamashita Y; Mushino T; Hosoi H; Sonoki T
    Rinsho Ketsueki; 2024; 65(3):169-174. PubMed ID: 38569861
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Differential prognostic values of the three AKT isoforms in acute myeloid leukemia.
    Corre E; Soum C; Pfeifer R; Bessière C; Dailhau S; Marbœuf C; Meggetto F; Touriol C; Récher C; Bousquet M; Pyronnet S
    Sci Rep; 2024 Mar; 14(1):7070. PubMed ID: 38528080
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Investigating the potential of single-cell DNA methylation data to detect allele-specific methylation and imprinting.
    Johnson ND; Cutler DJ; Conneely KN
    Am J Hum Genet; 2024 Apr; 111(4):654-667. PubMed ID: 38471507
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. AML with RUNX1::runx1t1 Cooperating two Mutations Relapsed Quickly after Achieving CR.
    XinhongYang ; Wu Y; Yang X; Wu X; Chen Y; Zhang R; Zhang Z
    Clin Lab; 2024 Mar; 70(3):. PubMed ID: 38469780
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Usefulness of KIT mutant transcript levels for monitoring measurable residual disease in t (8;21) acute myeloid leukemia.
    Sun Y; Wang X; Chen WM; Hao Y; Li LD; Li JY; Sun K; Shi ZY; Jiang H; Jiang Q; Huang XJ; Qin YZ
    Hematol Oncol; 2024 Mar; 42(2):e3264. PubMed ID: 38461410
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Functional characterization of cooperating MGA mutations in RUNX1::runx1t1 acute myeloid leukemia.
    Thomas ME; Qi W; Walsh MP; Ma J; Westover T; Abdelhamed S; Ezzell LJ; Rolle C; Xiong E; Rosikiewicz W; Xu B; Loughran AJ; Pruett-Miller SM; Janke LJ; Klco JM
    Leukemia; 2024 May; 38(5):991-1002. PubMed ID: 38454121
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::runx1t1/3 fusions.
    Tauziède-Espariat A; Lew-Derivry L; Abbou S; Métais A; Pierron G; Reynaud S; Masliah-Planchon J; Mariet C; Hasty L; Dangouloff-Ros V; Boddaert N; Csanyi M; Aline-Fardin A; Lamaison C; Chrétien F; Beccaria K; Puget S; Varlet P
    Acta Neuropathol Commun; 2024 Jan; 12(1):12. PubMed ID: 38243303
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Mixed-phenotype acute leukemia, T/megakaryoblastic: does it really exist?
    Mansoor N; Javed O; Rafiq N; Aali A; Meraj F
    J Hematop; 2023 Mar; 16(1):49-55. PubMed ID: 38175376
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Proteogenomic analysis reveals cytoplasmic sequestration of RUNX1 by the acute myeloid leukemia-initiating CBFB::MYH11 oncofusion protein.
    Day RB; Hickman JA; Xu Z; Katerndahl CD; Ferraro F; Ramakrishnan SM; Erdmann-Gilmore P; Sprung RW; Mi Y; Townsend RR; Miller CA; Ley TJ
    J Clin Invest; 2023 Dec; 134(4):. PubMed ID: 38061017
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. PASS-ALL study of paediatric-inspired versus adult chemotherapy regimens on survival of high-risk Philadelphia-negative B-cell acute lymphoblastic leukaemia with allogeneic haematopoietic stem cell transplantation.
    Wang Z; Fan Z; Wu Z; Xuan L; Li X; Tang B; Liu Y; He J; Huang K; Zhou X; Gao Y; Wang Q; Li X; Lin R; Xu N; Huang F; Wang S; Liang X; Zhang J; Liu X; Sun J; Liu Q; Zhou H
    Br J Haematol; 2024 Feb; 204(2):628-637. PubMed ID: 38050437
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Combination of eriocalyxin B and homoharringtonine exerts synergistic anti-tumor effects against t(8;21) AML.
    Lei YC; Chen XJ; Dai YT; Dai B; Wang JY; Li MH; Liu P; Liu H; Wang KK; Jiang L; Chen B
    Acta Pharmacol Sin; 2024 Mar; 45(3):633-645. PubMed ID: 38017299
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::runx1t1.
    Srinivasan S; Dhamne C; Patkar N; Chatterjee G; Moulik NR; Chichra A; Pallath A; Tembhare P; Shetty D; Subramanian PG; Narula G; Banavali S
    Pediatr Blood Cancer; 2024 Feb; 71(2):e30791. PubMed ID: 38014874
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Single-cell RNA-seq reveals novel immune-associated biomarkers for predicting prognosis in AML patients with RUNX1::runx1t1.
    Li XP; Dai Y; Zhang WN; Pan MM; Mao J; Zhao B; Jiang L; Gao Y
    Int Immunopharmacol; 2023 Dec; 125(Pt B):111178. PubMed ID: 37951201
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid leukemia Using Flow Cytometry.
    Lewis JE; Cooper LAD; Jaye DL; Pozdnyakova O
    Mod Pathol; 2024 Jan; 37(1):100373. PubMed ID: 37925056
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Acute myeloid leukemia with t (8;21) translocation diagnosed at 21 weeks of gestation resulting in full-term delivery without chemotherapy].
    Norihama Y; Nomura M; Oda Y; Kasuya Y; Takei T; Sato K; Ogura M; Kikuchi T; Abe Y; Ishida T; Kasai Y; Tsukada N
    Rinsho Ketsueki; 2023; 64(8):731-734. PubMed ID: 37673623
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia.
    Duan W; Yang S; Zhao T; Hu L; Qin Y; Jia J; Wang J; Lu S; Jiang H; Zhang X; Xu L; Wang Y; Lai Y; Shi H; Huang X; Jiang Q
    Ann Hematol; 2023 Oct; 102(10):2695-2705. PubMed ID: 37572135
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Development of a scoring system for predicting primary resistance to venetoclax plus hypomethylating agents (HMAs) in acute myeloid leukemia patients.
    Zong L; Yin M; Kong J; Zhang J; Song B; Zhu J; Xue S; Wu X; Wu D; Bao X; Qiu H
    Mol Carcinog; 2023 Oct; 62(10):1572-1584. PubMed ID: 37555764
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Integrative Prognostic Machine Learning Models in Mantle Cell Lymphoma.
    Hill HA; Jain P; Ok CY; Sasaki K; Chen H; Wang ML; Chen K
    Cancer Res Commun; 2023 Aug; 3(8):1435-1446. PubMed ID: 37538987
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cytogenetic Profiling In Paediatric Acute Leukaemia; A Report On 746 Newly Diagnosed Paediatric Cases Analyzing The Spectrum Of Recurring Chromosomal Rearrangements In B Cell Lymphoblastic And Acute Myeloid Leukaemia.
    Meraj F; Jamal S; Javed O; Maqsood S; Jabbar N; Mansoor N
    J Ayub Med Coll Abbottabad; 2023; 35(2):196-202. PubMed ID: 37422805
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 16.